Siga Technologies Inc (SIGA) Stock Price, Quote & News

Company Profile

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. Its lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 212 672 9100

Website: www.siga.com

Address:

31 East 62nd Street, New York, United States

RetrocognitionRune Dec. 27 at 4:46 PM

$SIGA The setup is defined by credibility, not hype; cost controls have to translate into healthier margins — clear evidence of repeatability would change the narrative. In the end, repeatable performance earns the premium.

1 · Reply

LouKojak Dec. 26 at 7:24 PM

$SIGA is not easy to predict but history says a very positive announcement is due in the next 90 days. Time to start buying and average down on dips.

0 · Reply

BoycottBets Dec. 25 at 2:39 PM

$SIGA Market behavior suggests the name is transitioning from speculation toward proof‑based evaluation. Margin stability needs to accompany any growth acceleration. Consistent milestones could shift perception faster than fundamentals alone. Over time, credibility will hinge on repeatable performance.

1 · Reply

DimebagDarrell_ Dec. 23 at 4:13 AM

$SIGA

0 · Reply

jlonards Dec. 19 at 7:28 PM

$SIGA Saga

0 · Reply

BostonNorth Dec. 18 at 2:54 PM

$SPRY $NDAQ $GME $KBIO $MIRM $SIGA Borrow cost is no longer cheap or stable…. Rent is going up…landlord knows supply is tight.

0 · Reply

Lopppendbuffet Dec. 11 at 8:17 PM

$SIGA

0 · Reply

jlonards Dec. 11 at 4:45 PM

$SIGA those $.60 dividends spit out $42.X million. Not chump change.

0 · Reply

petsaregood71 Dec. 11 at 2:40 PM

$SIGA The likelihood of SIGA securing a new contract is considered high due to several factors supporting U.S. biodefense preparedness: Stockpiling Mandate: The U.S. government (specifically the Administration for Strategic Preparedness and Response, or ASPR, which includes BARDA) mandates the stockpiling of two different smallpox antiviral treatments.

0 · Reply

petsaregood71 Dec. 11 at 2:35 PM

$SIGA SIGA Technologies does not have a new, long-term BARDA contract signed yet, but a request for proposal (RFP) for one is expected, with a potential contract award and initial deliveries in 2026. The company is currently operating under options and modifications to its existing 19C contract, which is nearing completion.

0 · Reply

SIGA Technologies, Inc. (SIGA) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 4:01 PM EST - 7 weeks ago

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2025

Oct 30, 2025, 7:30 AM EDT - 2 months ago

SIGA to Host Business Update Call on November 6, 2025 Following Release of Third-Quarter 2025 Results

Sep 1, 2025, 10:52 AM EDT - 4 months ago

7 Big Yields From The Beat-Up Healthcare Sector

BMY DOC LTC OHI PFE SILA

Aug 20, 2025, 2:00 AM EDT - 4 months ago

SIGA Technologies: Still Bullish, But Worth Trimming Ahead Of BARDA News

Aug 6, 2025, 1:59 AM EDT - 5 months ago

SIGA Technologies, Inc. (SIGA) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 4:01 PM EDT - 5 months ago

SIGA Reports Financial Results for Three and Six Months Ended June 30, 2025

Jul 29, 2025, 7:30 AM EDT - 5 months ago

SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results

May 8, 2025, 7:16 PM EDT - 8 months ago

SIGA Technologies, Inc. (SIGA) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:05 PM EDT - 8 months ago

SIGA Reports Financial Results for Three Months Ended March 31, 2025

May 1, 2025, 7:30 AM EDT - 8 months ago

SIGA to Host Business Update Call on May 8, 2025 Following Release of First-Quarter 2025 Results

Apr 8, 2025, 7:30 AM EDT - 9 months ago

SIGA Declares Special Cash Dividend of $0.60 Per Share

Apr 7, 2025, 3:02 AM EDT - 9 months ago

SIGA Technologies: Asymmetric Upside, If 2025 Goes Right

Mar 18, 2025, 7:30 AM EDT - 10 months ago

SIGA Appoints Retired General John M. Keane to its Board of Directors

Mar 11, 2025, 8:55 PM EDT - 10 months ago

SIGA Technologies, Inc. (SIGA) Q4 2024 Earnings Call Transcript

Mar 11, 2025, 4:05 PM EDT - 10 months ago

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2024

Mar 4, 2025, 7:30 AM EST - 10 months ago

SIGA to Host Business Update Call on March 11, 2025 Following Release of Fourth-Quarter and Full Year 2024 Financial Results

Jan 2, 2025, 7:30 AM EST - 1 year ago

TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses

Dec 10, 2024, 4:00 PM EST - 1 year ago

Interim Results from STOMP Study of SIGA's Tecovirimat in Treatment of Mpox Announced

Dec 2, 2024, 5:49 PM EST - 1 year ago

SIGA Technologies Vs Emergent BioSolutions: Product Portfolio And Future Outlook

EBS

Nov 21, 2024, 5:01 PM EST - 1 year ago

SIGA Technologies: Expansion Into mAbs Is Smart, But Eggs Remain In One Basket

Nov 8, 2024, 9:18 AM EST - 1 year ago

SIGA Technologies (SIGA) Shares Tumble After Mpox Therapy Fails, Chief Medical Officer Terminated - Hagens Berman

Nov 7, 2024, 8:55 PM EST - 1 year ago

SIGA Technologies, Inc. (SIGA) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 7:30 AM EDT - 1 year ago

SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial Results

Oct 23, 2024, 8:17 AM EDT - 1 year ago

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating SIGA Technologies, Inc. for potential violations of federal securities laws

Oct 22, 2024, 7:30 AM EDT - 1 year ago

SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies

Oct 8, 2024, 7:42 AM EDT - 1 year ago

Siga Technologies to supply mpox therapy in Morocco

Oct 8, 2024, 7:30 AM EDT - 1 year ago

SIGA Announces Agreement to Supply TPOXX® in Morocco

Oct 3, 2024, 12:00 PM EDT - 1 year ago

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors

Oct 2, 2024, 3:03 PM EDT - 1 year ago

The Law Offices of Frank R. Cruz Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors

Sep 27, 2024, 8:22 AM EDT - 1 year ago

Wolf Haldenstein Adler Freeman & Herz LLP Announces that it is Investigating SIGA Technologies, Inc. for Potential Violations of Federal Securities Laws

RetrocognitionRune Dec. 27 at 4:46 PM

1 · Reply

LouKojak Dec. 26 at 7:24 PM

$SIGA is not easy to predict but history says a very positive announcement is due in the next 90 days. Time to start buying and average down on dips.

0 · Reply

BoycottBets Dec. 25 at 2:39 PM

1 · Reply

DimebagDarrell_ Dec. 23 at 4:13 AM

$SIGA

0 · Reply

jlonards Dec. 19 at 7:28 PM

$SIGA Saga

0 · Reply

BostonNorth Dec. 18 at 2:54 PM

$SPRY $NDAQ $GME $KBIO $MIRM $SIGA Borrow cost is no longer cheap or stable…. Rent is going up…landlord knows supply is tight.

0 · Reply

Lopppendbuffet Dec. 11 at 8:17 PM

$SIGA

0 · Reply

jlonards Dec. 11 at 4:45 PM

$SIGA those $.60 dividends spit out $42.X million. Not chump change.

0 · Reply

petsaregood71 Dec. 11 at 2:40 PM

0 · Reply

petsaregood71 Dec. 11 at 2:35 PM

0 · Reply

petsaregood71 Dec. 11 at 2:31 PM

$SIGA GOOG AI ----SIGA Technologies is currently in negotiations with the U.S. government for a new long-term BARDA contract. The exact value is not yet finalized, but company officials and market analysts anticipate it could surpass the value of the previous contract, potentially reaching over $700 million to over $1 billion in total value over a 5 to 10-year period.

1 · Reply

SuperGreenToday Dec. 11 at 3:26 AM

$SIGA Share Price: $6.25 Contract Selected: Jun 18, 2026 $6.0 Calls Buy Zone: $0.84 – $1.04 Target Zone: $1.50 – $1.84 Potential Upside: 69% ROI Time to Expiration: 189 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

BostonNorth Dec. 10 at 9:45 PM

$SPRY $ENPH $GME $SIGA $SPRY $SRPT Borrow pool is shrinking again… Good luck to all, still not too late!

2 · Reply

BostonNorth Dec. 9 at 7:02 PM

$SPRY $$SIGA $SRPT $KBIO $ENPH $GME Classic short squeeze setup (opinion only but mechanical facts back it up) ARS PHARMACEUTICALS! FINRA-reported off-exchange short volume was unusually high…. roughly 70% of all reported volume. What’s notable is that despite this level of short participation, SPRY still closed green, which is a very bullish signal. Historically, across two decades of market data, when short volume reaches these extremes yet the stock continues to rise, it reflects a lack of natural selling pressure. In environments like this, any positive catalyst…commercial, regulatory, or operational, tends to produce an outsized upside response because the market is structurally tight minimal tradable shares (AKA micro float) majority others are locked up. Probably 1.5 to 4.0 million actual shares that trade based on SPRY historical volume. #shortsqueeze incoming!?

3 · Reply

PennyFlipperMagoo Dec. 9 at 12:17 PM

$SIGA 😐🫣😬🤫 https://www.aol.co.uk/articles/know-mpox-strain-identified-england-181653889.html

1 · Reply

jlonards Dec. 8 at 5:37 PM

$SIGA Bueler?

0 · Reply

BostonNorth Dec. 3 at 11:09 PM

$SIGA 🧨💪

0 · Reply

Will2ride1 Dec. 3 at 11:02 PM

$SIGA The next infectious disease coming is not a question of if ...but when.

0 · Reply

jlonards Dec. 3 at 10:09 PM

$SIGA 23,560 shares traded after hours. +$.25. Someone w a few coins in their pocket is in the loop.

0 · Reply

jlonards Dec. 3 at 2:46 PM

$SIGA always has a lack of communication w shareholders because they don't want to upset anyone at BARDA. The important thing is, there is mutual respect and BARDA needs TPOXX/ST-246

1 · Reply

BinaryLogic Nov. 27 at 4:42 PM

$SIGA Admittedly-I need greater clarity on Q3 revenue and guidance to 2026. That said-the stock was grossly Oversold following ER, consolidating now at/around $6.0. The Company has a very strong financial position [53% EBITDA, 43% Net Margin, Current: 9, Net Debt<0, Consistent Positive FCF, 40% ROE]. 25-50% upside from this level (IMO), should Q3-2025 prove anomalous and government contracts support ongoing profitability, FCF.

1 · Reply

Will2ride1 Nov. 26 at 2:09 AM

$SIGA I like the massive dip...im in and very bully

0 · Reply

Market Cap	449.00M
Revenue (ttm)	138.72M
Net Income (ttm)	59.21M
EPS (ttm)	N/A
PE Ratio	6.11
Forward PE	N/A
Profit Margin	42.68%
Debt to Equity Ratio	0.00

Volume	318,500
Avg Vol	387,928
Day's Range	N/A - N/A
Shares Out	71.61M
Stochastic %K	21%
Beta	0.98
Analysts	Strong Buy
Price Target	$11.00